Item 9 Labs Corp (PK:INLB)

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 2111 E HIGHLAND AVE, SUITE B375
PHOENIX AZ 85016
Tel: N/A
Website: https://item9labscorp.com
IR: See website
<
Key People
Christopher Wolven
Chief Operating Officer
   
Business Overview
Item 9 Labs Corp. is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The Company also offers a dispensary franchise model through the national Unity Rd. retail brand. The Company offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vaporizer (vape) products, as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company operates through two segments: Cultivation and Franchising. Its product lines include Item 9 Labs Flower, Item 9 Labs Concentrates, and Orion 710.
Financial Overview
For the nine months ended 30 June 2023, Item 9 Labs Corp revenues decreased 12% to $15.7M. Net loss decreased 1% to $12.6M. Revenues reflect Cultivation segment decrease of 13% to $15.1M, Franchising segment decrease of 21% to $222K. Lower net loss reflects Cultivation segment income increase of 58% to $6.3M, Franchising segment loss decrease of 23% to $2.1M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.13 to -$0.12.
Employees: 97 as of Jan 13, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $33.75M as of Jun 30, 2023
Annual revenue (TTM): $19.69M as of Jun 30, 2023
EBITDA (TTM): -$7.44M as of Jun 30, 2023
Net annual income (TTM): -$31.03M as of Jun 30, 2023
Free cash flow (TTM): -$2.60M as of Jun 30, 2023
Net Debt Last Fiscal Year: $33.72M as of Jun 30, 2023
Shares outstanding: 102,362,271 as of Aug 21, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.